Twist Bioscience Reports 22% Fiscal 2026 Revenue Growth to $459.4 Million
Twist Bioscience reported fiscal 2026 revenue of $459.4 million, up 22% year over year, and fourth-quarter revenue of $126.6 million, up 28%. Full-year gross margin improved to 52.4%, and adjusted EBITDA reached $2.2 million in the fourth quarter. The company forecast fiscal 2027 revenue of $550 mi…